These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 657405)

  • 21. 5-cyclohexyl-1-hydroxyacetylindans as potential antiinflammatory agents.
    Juby PF; Hudyman TW; Partyka RA
    J Med Chem; 1972 Jan; 15(1):120-1. PubMed ID: 5007087
    [No Abstract]   [Full Text] [Related]  

  • 22. (1-oxo-2-substituted-5-indanyloxy)acetic acids, a new class of potent renal agents possessing both uricosuric and saluretic activity. A reexamination of the role of sulfhydryl binding in the mode of action of acylphenoxyacetic acidsaluretics.
    Cragoe EJ; Schultz EM; Schneeberg JD; Stokker GE; Woltersdorf OW; Fanelli GM; Watson LS
    J Med Chem; 1975 Feb; 18(2):225-8. PubMed ID: 1120997
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of S-oxidation on the anticoagulant effects of 4-hydroxycoumarins, 4-hydroxy-2-pyrones and 1,3-indanediones].
    Rehse K; Rüther D
    Arch Pharm (Weinheim); 1984 Mar; 317(3):262-7. PubMed ID: 6732447
    [No Abstract]   [Full Text] [Related]  

  • 24. Design and synthesis of N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L -alanyl]-N-(indan-2-yl)glycine (CV-3317), a new, potent angiotensin converting enzyme inhibitor.
    Miyake A; Itoh K; Oka Y
    Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2852-8. PubMed ID: 3021350
    [No Abstract]   [Full Text] [Related]  

  • 25. The concise synthesis of chalcone, indanone and indenone analogues of combretastatin A4.
    Kerr DJ; Hamel E; Jung MK; Flynn BL
    Bioorg Med Chem; 2007 May; 15(9):3290-8. PubMed ID: 17360188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Unexpected anti-inflammatory activity of rigid structures derived from 6-arylpyridazinone antihypertensive agents. II. Synthesis and activity of 5H-indeno(1,2-c)pyridazine and 5H-indeno(1,2-c)pyridazin-3-one].
    Loriga M; Aimé Pinna G; Cignarella G; Schiatti G
    Farmaco Sci; 1979 Jan; 34(1):72-80. PubMed ID: 553822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of prostaglandin biosynthesis by clidanac and related compounds: structural and conformational requirements for PG synthetase inhibition.
    Tamura S; Kuzuna S; Kawai K
    J Pharm Pharmacol; 1981 Jan; 33(1):29-32. PubMed ID: 6114148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284), a new antiinflammatory agent.
    Noguchi S; Kishimoto S; Minamida I; Obayashi M; Kawakita K
    Chem Pharm Bull (Tokyo); 1971 Mar; 19(3):646-8. PubMed ID: 5553051
    [No Abstract]   [Full Text] [Related]  

  • 29. [Synthesis of indanones and tetralones as new potential schistosomicidals].
    Gan PZ; Zhou DH; Yao RH; Ma Z; Ma RS; Xiang LZ; Huang LS
    Yao Xue Xue Bao; 1985 May; 20(5):345-52. PubMed ID: 4083021
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis, toxicity, and cardiovascular properties of N-aralkyl- and N-acyl-5-aminoethylindans.
    Solomons WE; Mathison IW; Jones RH; Wojciechowski NJ; Lawson JW
    J Pharm Sci; 1978 Mar; 67(3):314-7. PubMed ID: 641714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiinflammatory 2-aryl-1,3-indandiones.
    Lombardino JG; Wiseman EH
    J Med Chem; 1968 Mar; 11(2):342-7. PubMed ID: 5690957
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological study of a series of indandione derivatives proposed as anti-inflammatory agents].
    Rosini S; Trallori L; Silvestri S
    Farmaco Sci; 1976 May; 31(5):315-21. PubMed ID: 1269735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-complement activity in a series of substituted 2-aryl-1,3-indandiones; absence of correlation with the anti-carrageenan oedema effects.
    van der Goot H; Timmerman H; Asghar SS; Siddiqui AH
    Agents Actions; 1984 Oct; 15(3-4):371-6. PubMed ID: 6524526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances in the Synthesis of Indanes and Indenes.
    Gabriele B; Mancuso R; Veltri L
    Chemistry; 2016 Apr; 22(15):5056-94. PubMed ID: 26788795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synthesis and antiplatelet aggregating activity of several thiopyranylidene ketones and benzylidene indanones].
    Varache-Beranger M; Nuhrich A; Devaux G
    Farmaco Sci; 1987 Jun; 42(6):465-73. PubMed ID: 3653390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and pharmacological properties of N-arylpiperazine-N'-alkylindanes.
    Misztal S; Chojnacka-Wójcik E; Bartyzel P; Moskal A; Tatarczyńska E; Wiczyńska B; Lewandowska A
    Pol J Pharmacol Pharm; 1984; 36(6):697-703. PubMed ID: 6336001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroaromatic analogs of 2-nitro-1,3-indandiones.
    Buckle DR; Morgan NJ; Smith H
    J Med Chem; 1975 Feb; 18(2):203-6. PubMed ID: 804554
    [No Abstract]   [Full Text] [Related]  

  • 38. 2-Indanpropionic acids: structural leads for prostaglandin F2alpha antagonist development.
    Witiak DT; Kakodkar SV; Johnson TP; Baldwin JR; Rahwan RG
    J Med Chem; 1979 Jan; 22(1):77-81. PubMed ID: 423186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of indanpropionic acids as uterine relaxants.
    Witiak DT; Hassan AM; Del Vecchio FR; Brumbaugh RJ; Rahwan RG
    J Med Chem; 1984 Sep; 27(9):1215-9. PubMed ID: 6471075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and pharmacological properties of N-aroyl-beta-(1-indanyl)-ethylamines.
    Misztal S; Bartyzel P; Chojnacka-Wójcik E; Tatarczyńska E; Sypniewska M
    Pol J Pharmacol Pharm; 1980; 32(4):577-85. PubMed ID: 7255273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.